
Intussusception Market Report 2026
Global Outlook – By Type (Idiopathic Intussusception, Secondary Intussusception), By Treatment (Enema Reduction, Surgery, Other Treatment), By Diagnosis (Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)), By End-User (Hospitals, Clinics, Other End-User) - Market Size, Trends, And Global Forecast 2026-2035
Intussusception Market Overview
• Intussusception market size has reached to $4.67 billion in 2025 • Expected to grow to $5.68 billion in 2030 at a compound annual growth rate (CAGR) of 4% • Growth Driver: Increasing Incidence of Intestinal Disorder to Drive Intussusception Market Growth • North America was the largest region in 2025.What Is Covered Under Intussusception Market?
Intussusception is a medical condition in which one portion of the intestine slides into an adjacent section of the intestine, blocking the flow of food, fluids, and gas through the affected part of the intestine, leading to symptoms such as severe abdominal pain, vomiting, and bloody stools. It is usually diagnosed based on the symptoms, physical examination, and imaging tests. The main types of intussusception are idiopathic intussusception and secondary intussusception. Idiopathic intussusception is a medical condition characterized by the telescoping or invagination of one portion of the intestine into another, causing a blockage or obstruction that can be treated non-surgically through a procedure called pneumatic or hydrostatic reduction. The method of treatment includes enema reduction, surgery, and others, that involve diagnosis methods such as barium enema, ultrasound, and X-ray. These are provided by hospitals, clinics, and others.
What Is The Intussusception Market Size and Share 2026?
The intussusception market size has grown steadily in recent years. It will grow from $4.67 billion in 2025 to $4.85 billion in 2026 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to high incidence of pediatric gastrointestinal emergencies, widespread use of barium enema for diagnosis and treatment, established surgical intervention protocols, increasing availability of hospital emergency services, growing awareness of childhood abdominal disorders.What Is The Intussusception Market Growth Forecast?
The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.68 billion in 2030 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to advancements in diagnostic imaging technologies, increasing emphasis on early and non-invasive treatment approaches, expansion of pediatric emergency care infrastructure, growing training programs for gastrointestinal emergencies, rising healthcare access in developing regions. Major trends in the forecast period include increasing use of ultrasound as first-line diagnostic tool, growing preference for non-surgical enema reduction procedures, rising focus on early diagnosis in pediatric emergency care, increasing adoption of minimally invasive surgical techniques, growing awareness and training for rapid intussusception management.Global Intussusception Market Segmentation
1) By Type: Idiopathic Intussusception, Secondary Intussusception 2) By Treatment: Enema Reduction, Surgery, Other Treatment 3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT) 4) By End-User: Hospitals, Clinics, Other End-User Subsegments: 1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception 2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical IntussusceptionWhat Are The Drivers Of The Intussusception Market?
The rising incidence of intestinal disorders is expected to propel the growth of the intussusception market going forward. An intestinal disorder refers to any medical condition or health issue that affects the normal functioning of the intestines, which are parts of the digestive system responsible for absorbing nutrients and eliminating waste from the body. An increasing incidence of intestinal disorders such as inflammatory bowel disease and gastrointestinal cancers can lead to earlier diagnosis, improved treatment options, and enhanced support for intussusception patients, ultimately benefiting their health and well-being. For instance, in January 2024, according to the Colorectal Cancer Alliance, a US-based nonprofit patient advocacy and research organization, an estimated 152,810 new colorectal cancer cases are expected in 2024, including 106,590 colon cancer cases and 46,220 rectal cancer cases. The Alliance also reports an anticipated 53,010 deaths from colorectal cancer in 2024, representing a slight increase from last year’s estimate of 52,550 deaths. Therefore, the rising incidence of intestinal disorders will drive the growth of the intussusception industry. The increase in healthcare spending is driving the growth of the intussusception market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending involves the allocation of financial resources to address medical needs, and the occurrence of conditions such as intussusception contributes to increased spending by necessitating medical interventions, diagnostic procedures, and potential surgical treatments, thereby impacting overall healthcare expenditure. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based Institute for Health Information, in 2023, total health spending in Canada is projected to reach $344 billion, equating to $8,740 per person. This marks a 2.8% increase compared to the previous year, which saw only a 1.5% growth in health spending in 2022, indicating a notable rebound in healthcare investment. Therefore, an increase in healthcare spending is driving the growth of the intussusception industry The rising pediatric vaccination programs are expected to propel the growth of the intussusception market going forward. Pediatric vaccination programs are organized public-health initiatives that deliver routine immunizations to infants and young children to prevent infectious diseases. The rise in pediatric vaccination programs is driven by government-led immunization initiatives, as expanded public vaccination campaigns improve vaccine access and increase routine immunization coverage among infants and young children. Pediatric vaccination programs support the early detection, clinical management, and post-vaccination surveillance of rare bowel complications such as intussusception associated with rotavirus immunization, thereby strengthening overall vaccine safety monitoring and public confidence. For instance, in May 2025, according to the UK Health Security Agency, a UK-based government agency, during the 2023–2024 season, a school-based programme targeting all children aged 4 to 16 years (Reception to Year 11) in England saw 52.2% of eligible children in Reception to Year 9 (3,498,576 out of 6,708,016) receive the vaccine. This is slightly higher than the 51.9% coverage (3,502,566 out of 6,747,523) recorded in the 2022–2023 season. Therefore, the rising pediatric vaccination programs are driving the growth of the intussusception industry.Key Players In The Global Intussusception Market
Major companies operating in the intussusception market are Abbott Laboratories, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, GE HealthCare Technologies Inc., Steris Plc, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Richard Wolf GmbH, Karl Storz SE And Co. KG.Regional Outlook
North America was the largest region in the intussusception market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Intussusception Market?
The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Intussusception Market Report 2026?
The intussusception market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Intussusception Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.85 billion |
| Revenue Forecast In 2035 | $5.68 billion |
| Growth Rate | CAGR of 4.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Treatment, Diagnosis, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Abbott Laboratories, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, GE HealthCare Technologies Inc., Steris Plc, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Richard Wolf GmbH, Karl Storz SE And Co. KG. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
